Blood cancers, Myeloma
Results
Phase 3
This trial looked at 3 drugs called bortezomib, panobinostat and dexamethasone for myeloma that had come back or stopped responding to treatment.
Recruitment start: 29 April 2010
Recruitment end: 31 March 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Jamie Cavenagh
Experimental Cancer Medicine Centre (ECMC)
NHS Research Scotland Permissions Coordinating Centre
NIHR Clinical Research Network: Cancer
Novartis
Last reviewed: 27 May 2015
CRUK internal database number: 6472
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
